MedTrace Logo

Study of Treatment Effects of Combination Therapy of Lucentis Plus Reduced Fluence PDT With Visudyne in Patients With Exudative AMD

NCT00455871 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2008-05-09

No results posted yet for this study

Summary

The purpose of this study is to determine the benefits, if any, of combination therapy with Lucentis plus reduced fluence photodynamic therapy with Visudyne.

Conditions

  • Age-Related Macular Degeneration

Interventions

DRUG

reduced fluence photodynamic therapy with Visudyne

reduced fluence photodynamic therapy with visudyne

DRUG

Lucentis

Lucentis intravitreal injection

Sponsors & Collaborators

  • QLT Inc.

    collaborator INDUSTRY

  • Barnes Retina Institute

    lead OTHER

Principal Investigators

  • Gaurav K. Shah, MD · Barnes Retina Institute

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-04-30
Primary Completion
2010-10-31
Completion
2010-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00455871 on ClinicalTrials.gov